User profiles for Mark J Caulfield

Mark Caulfield

William Harvey Research Institute & the NIHR Biomedical Research Centre at Barts, Queen …
Verified email at qmul.ac.uk
Cited by 132842

[HTML][HTML] SLC2A9 is a high-capacity urate transporter in humans

MJ Caulfield, PB Munroe, D O'Neill, K Witkowska… - PLoS …, 2008 - journals.plos.org
Background Serum uric acid levels in humans are influenced by diet, cellular breakdown,
and renal elimination, and correlate with blood pressure, metabolic syndrome, diabetes, gout, …

[HTML][HTML] Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

…, E Ambrosioni, M Burnier, MJ Caulfield… - Blood …, 2009 - Taylor & Francis
… have been based on the report from the PROGRESS trial (Citation89) that in patients with
a previous stroke or transient ischemic attack BP lowering was accompanied by a marked

Common variants near MC4R are associated with fat mass, weight and risk of obesity

…, DP Strachan, WH Ouwehand, MJ Caulfield… - Nature …, 2008 - nature.com
To identify common variants influencing body mass index (BMI), we analyzed genome-wide
association data from 16,876 individuals of European descent. After previously reported …

[HTML][HTML] Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1· 25 million people

…, AD Shah, S Denaxas, IR White, MJ Caulfield… - The Lancet, 2014 - thelancet.com
Background The associations of blood pressure with the different manifestations of incident
cardiovascular disease in a contemporary population have not been compared. In this study, …

[HTML][HTML] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …

…, I Ford, JK Cruickshank, MJ Caulfield, J Salsbury… - The Lancet, 2015 - thelancet.com
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

…, NO Stitziel, JG Smith, DI Chasman, MJ Caulfield… - The Lancet, 2015 - thelancet.com
Background Genetic variants have been associated with the risk of coronary heart disease.
In this study, we tested whether or not a composite of these variants could ascertain the risk …

[HTML][HTML] Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution

…, JCM Witteman, C Zhang, W Zhang, MJ Caulfield… - PLoS …, 2009 - journals.plos.org
To identify genetic loci influencing central obesity and fat distribution, we performed a meta-analysis
of 16 genome-wide association studies (GWAS, N = 38,580) informative for adult …

Whole-genome sequencing of patients with rare diseases in a national health system

…, DL Bennett, P Calleja, K Carss, MJ Caulfield… - Nature, 2020 - nature.com
Most patients with rare diseases do not receive a molecular diagnosis and the aetiological
variants and causative genes for more than half such disorders remain to be discovered 1 . …

Rare and low-frequency coding variants alter human adult height

…, AA Burt, AS Butterworth, DJ Carey, MJ Caulfield… - Nature, 2017 - nature.com
Height is a highly heritable, classic polygenic trait with approximately 700 common associated
variants identified through genome-wide association studies so far. Here, we report 83 …

Exome-wide association study of plasma lipids in> 300,000 individuals

…, I Brandslund, M Brown, F Busonero, MJ Caulfield… - Nature …, 2017 - nature.com
We screened variants on an exome-focused genotyping array in> 300,000 participants (replication
in> 280,000 participants) and identified 444 independent variants in 250 loci …